This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignees: Centre Eugene Marquis, Ecole Nationale Superieure De Chime, Université De Rennes I. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Nicolas Lepareur
Introduction
Nicolas Lepareur is a notable inventor based in Vern-sur-Seiche, France. He has made significant contributions to the field of therapeutic compositions, particularly through his innovative patent. His work reflects a commitment to advancing medical science and improving therapeutic options.
Latest Patents
Nicolas Lepareur holds a patent for a composition intended for therapeutic use, which includes an organic lipid phase and a rare-earth radioisotope complex. The invention relates to a therapeutic composition that features a complex represented by the formula (1), which includes a rare-earth radioisotope in ionic form. This complex is solubilized in an organic lipophilic phase, denoted as [M(L)], where M represents the rare-earth radioisotope in ionic form, and L signifies a tropolone ligand or a ligand derived from tropolone. This innovative approach has the potential to enhance therapeutic applications significantly.
Career Highlights
Throughout his career, Nicolas Lepareur has worked with esteemed institutions such as the École Nationale Supérieure de Chimie and the Centre Eugène Marquis. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in therapeutic compositions.
Collaborations
Nicolas Lepareur has collaborated with notable colleagues, including Nicolas Noiret and Etienne Garin. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking innovations.
Conclusion
Nicolas Lepareur's contributions to the field of therapeutic compositions exemplify his dedication to innovation and medical advancement. His patent and collaborative efforts highlight the importance of research and development in creating effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile